David Y. Liu, Chief Scientific Officer at Protagonist Therapeutics, Inc (PTGX), sold 875 shares at $20.00 ($18K) on 2018-01-16, disclosed to the SEC on 2018-01-17.
Scheduled sale ($18k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PTGX | SELL | 2019-03-04 | $7K | — | Filing → |
| PTGX | SELL | 2019-02-08 | $30K | — | Filing → |
| PTGX | SELL | 2018-03-13 | $75K | — | Filing → |